Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2017 | Novel therapies for the treatment of bladder cancer

Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute, London, UK, discusses the RANGE trial, a Phase III clinical trial investigating the effectiveness of ramucirumab in treating bladder cancer (NCT02426125). He raises the possibility of applying chemotherapy, immunotherapy and targeted therapy in future treatment of cancer and states that current research must be focused on investigating these forms of therapies in combination to evaluate their effectiveness. This interview was filmed at the American Society of Oncology (ASCO) 2017 Annual Meeting in Chicago, IL.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.